Effect of clinoptilolite on structure and drug release behavior of chitosan/thyme oil γ‐Cyclodextrin inclusion compound hydrogels

Zeolites as Ingredients of Medicinal Products

Development of new medicinal products for particular therapeutic treatment or for better manipulations with better quality and less side effects are possible as a result of advanced inorganic and organic materials application, among which zeolites, due to their properties and versatility, have been gaining attention. This paper is an overview of the development in the use of zeolite materials and their composites and modifications as medicinal products for several purposes such as active agents, carriers, for topical treatments, oral formulations, anticancer, the composition of theragnostic systems, vaccines, parenteral dosage forms, tissue engineering, etc. The objective of this review is to explore the main properties of zeolites and associate them with their drug interaction, mainly addressing the advances and studies related to the use of zeolites for different types of treatments due to their zeolite characteristics such as molecule storage capacity, physical and chemical stability, cation exchange capacity, and possibility of functionalization. The use of computational tools to predict the drug-zeolite interaction is also explored. As conclusion was possible to realize the possibilities and versatility of zeolite applications as being able to act in several aspects of medicinal products.

Biaxial electrospun nanofibers based on chitosan-poly (vinyl alcohol) and poly (Ɛ-caprolactone) modified with CeAlO3 nanoparticles as potential wound dressing materials

A two-nozzle electrospinning method was employed to fabricate hybrid nanofibers based on chitosan/polyvinyl alcohol (CS/PVA), with a ratio of 50:50, and poly (Ɛ-caprolactone) (PCL). CeAlO₃ nanoparticles were synthesized by combustion method and utilized to improve the nanofiber's properties for wound dressing application. Cephalexin (CFX), as an antibiotic model, was also incorporated into the hydrophilic nanofibers. X-ray diffraction showed an increase in crystallinity when CeAlO₃-NPs were present in the nanofibers. Water vapor transmission rates in the samples were calculated as 2201-2627 g m^-2 day^-1, all within the normal range of ideal wound dressings. Mechanical studies revealed a 43 % and 85 % increase in tensile strength and modulus when CeAlO₃-NPs were incorporated. In vitro drug release tests were conducted to simulate drug release, and the neat fibers showed faster release than the modified fibers. The MTT assay and cell morphology experiments showed that CeAlO₃-NPs did not affect the nanofiber's biocompatibility and fibroblast cells could better grow, differentiate and cover the prepared hybrid scaffold surface compared to the neat fibers. Taking the results of our study into account, we believe the prepared nanofibrous has the potential for use as a low-cost, effective wound dressing.

Potential of plant secondary metabolite-based polymers to enhance wound healing

There is a global epidemic of non-healing wounds. Chronic inflammation, overexpression of pro-inflammatory cytokines, oxidative stress and bacterial infection are implicated in delayed wound healing. Natural extracts are a rich source of bioactive molecules called plant secondary metabolites (PSMs) that include terpenes and phenols. These molecules may facilitate wound healing through their antioxidant, anti-inflammatory, and antibacterial activity. After briefly outlining the process of wound healing and how it is compromised in chronic wounds, this review focuses on investigating how PSMs-based polymers may improve wound healing. Best methods for incorporating PSMs into wound dressings are reviewed and critically compared. The exiting body of literature strongly suggests that PSMs-based polymers incorporated into wound dressings could have clinical value in aiding wound healing. STATEMENT OF SIGNIFICANCE: Chronic wounds develop by the persistence of inflammation, oxidative stress and infection. Chronic wounds affect the worldwide population, by reducing quality of life of patients with significant cost to healthcare systems. To help chronic wounds to heal and overcome this burden, materials with anti-inflammatory, antioxidant and antibacterial properties are required. Plant secondary metabolites (PSMs) are volatile materials that have all these properties. PSMs-based polymers can be fabricated by polymerization techniques. The present review provides an overview of the state-of-the-art of the wound healing mechanisms of PSMs. Current developments in the field of PSMs-based polymers are reviewed and their potential use as wound dressings is also covered.

CMC-based hydrogels loaded with Hypericum perforatum nanoemulsion for potential wound dressing applications

Wound healing is a complicated process requiring appropriate environment to accelerate healing process. In the recent years, many wound dressings have been developed for treating various kinds of wounds. In this study, we aimed to develop a novel dressing with high ability of burn wound healing and minimum side effects. Carboxymethyl cellulose (CMC) based hydrogels containing Hypericum perforatum were developed by grafting methacrylic acid and acrylamide onto CMC to produce a good mechanical strength dressing. Covalent crosslinking, which is responsible for stable mechanical structure, led to a 3D structure with appropriate water vapor transmission rate (2950 g/m2/day), controlled drug release (33% in 78 h), and great burn healing ability (almost complete healing in 10 day). The hydrogel has proper antimicrobial activity against the tested microorganisms. Zone of inhibition against E.coli was the higher in comparison with S. aureus and Candida. Minimum inhibitory concentration (MIC) for C. albicans, S. aureus, and E. coli were as 6, 4, and 5 mg/ml of H. perforatum. In vivo experiments on rats revealed that wound healing process by loaded hydrogels was faster in comparison with control group. All the results indicated that prepared hydrogel has the capability to accelerate burn wound healing process.

Cyclodextrin-Containing Hydrogels: A Review of Preparation Method, Drug Delivery, and Degradation Behavior

Hydrogels possess porous structures, which are widely applied in the field of materials and biomedicine. As a natural oligosaccharide, cyclodextrin (CD) has shown remarkable application prospects in the synthesis and utilization of hydrogels. CD can be incorporated into hydrogels to form chemically or physically cross-linked networks. Furthermore, the unique cavity structure of CD makes it an ideal vehicle for the delivery of active ingredients into target tissues. This review describes useful methods to prepare CD-containing hydrogels. In addition, the potential biomedical applications of CD-containing hydrogels are reviewed. The release and degradation process of CD-containing hydrogels under different conditions are discussed. Finally, the current challenges and future research directions on CD-containing hydrogels are presented.

The Advantages of Polymeric Hydrogels in Calcineurin Inhibitor Delivery

In recent years, polymeric hydrogels (PolyHy) have been extensively explored for their applications in biomedicine as biosensors, in tissue engineering, diagnostic processes, and drug release. The physical and chemical properties of PolyHy indicate their potential use in regulating drug delivery. Calcineurin inhibitors, particularly cyclosporine (CsA) and tacrolimus (TAC), are two important immunosuppressor drugs prescribed upon solid organ transplants. Although these drugs have been used since the 1970s to significantly increase the survival of transplanted organs, there are concerns regarding their undesirable side effects, primarily due to their highly variable concentrations. In fact, calcineurin inhibitors lead to acute and chronic toxicities that primarily cause adverse effects such as hypertension and nephrotoxicity. It is suggested from the evidence that the encapsulation of calcineurin inhibitors into PolyHy based on polysaccharides, specifically alginate (Alg), offers effective drug delivery with a stable immunosuppressive response at the in vitro and in vivo levels. This not only may reduce the adverse effects but also would improve the adherence of the patients by the effective preservation of drug concentrations in the therapeutic ranges.